Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
Gislaine Z. Réus, Indianara R. T. Becker, Giselli Scaini, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 81, pp. 55-63
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Gut microbiota–brain axis in depression: The role of neuroinflammation
Anelise S. Carlessi, Laura A. Borba, Alexandra I. Zugno, et al.
European Journal of Neuroscience (2019) Vol. 53, Iss. 1, pp. 222-235
Open Access | Times Cited: 189
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 117
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marta Marszałek‐Grabska, Katarzyna Walczak, Kinga Gaweł, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107845-107845
Open Access | Times Cited: 97
Maternal immune activation induced by lipopolysaccharide triggers immune response in pregnant mother and fetus, and induces behavioral impairment in adult rats
Lutiana R. Simões, Gustavo Sangiogo, Michael Hikaru Tashiro, et al.
Journal of Psychiatric Research (2018) Vol. 100, pp. 71-83
Closed Access | Times Cited: 68
The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways
Xiuxia Yuan, Yulin Kang, Chuanjun Zhuo, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 512, Iss. 2, pp. 373-380
Closed Access | Times Cited: 68
Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats
Gislaine Z. Réus, Ritele H. Silva, Airam B. de Moura, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 2, pp. 1096-1108
Closed Access | Times Cited: 67
IDO and TDO as a potential therapeutic target in different types of depression
Yanjie Qin, Nanxi Wang, Xinlin Zhang, et al.
Metabolic Brain Disease (2018) Vol. 33, Iss. 6, pp. 1787-1800
Closed Access | Times Cited: 59
Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease
Martin Hajšl, Alžběta Hlaváčková, K Broulíková, et al.
Metabolites (2020) Vol. 10, Iss. 5, pp. 208-208
Open Access | Times Cited: 59
An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway
Laiba Jamshed, Amrita Debnath, Shanza Jamshed, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6300-6300
Open Access | Times Cited: 34
Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction
Deepak Rathour, Shruti Shah, Sabiya Khan, et al.
Behavioural Brain Research (2022) Vol. 436, pp. 114081-114081
Closed Access | Times Cited: 33
The Tryptophan Catabolite or Kynurenine Pathway’s Role in Major Depression
Abbas F. Almulla, Michaël Maes
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 21, pp. 1731-1735
Open Access | Times Cited: 22
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 13
d-Limonene protects PC12 cells against corticosterone-induced neurotoxicity by activating the AMPK pathway
Xueping Tang, Xiao-hua Guo, Di Geng, et al.
Environmental Toxicology and Pharmacology (2019) Vol. 70, pp. 103192-103192
Closed Access | Times Cited: 39
Inflammatory Pathways in Psychiatric Disorders: the Case of Schizophrenia and Depression
Tami Feng, Ashutosh Tripathi, Anilkumar Pillai
Current Behavioral Neuroscience Reports (2020) Vol. 7, Iss. 3, pp. 128-138
Open Access | Times Cited: 34
Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
Kwangsik Nho, Alexandra Kueider‐Paisley, Matthias Arnold, et al.
Brain Communications (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 28
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders
Michael Y. Bai, David B. Lovejoy, Gilles J. Guillemin, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 1-2, pp. 19-33
Open Access | Times Cited: 25
Oxidative Stress and Neurodevelopmental Outcomes in Rat Offspring with Intrauterine Growth Restriction Induced by Reduced Uterine Perfusion
Marcelo E. Rains, Colin Muncie, Yi Pang, et al.
Brain Sciences (2021) Vol. 11, Iss. 1, pp. 78-78
Open Access | Times Cited: 23
Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression
Yanmei Chen, Jiahui Zhang, Yueying Yang, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 12, pp. 4339-4355
Closed Access | Times Cited: 18
Oxidative stress impairs cognitive function by affecting hippocampal fimbria volume in drug-naïve, first-episode schizophrenia
Rufei Jia, Xiuxia Yuan, Xiaoyun Zhang, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Protective Role of UCP2 in Oxidative Stress and Apoptosis during the Silent Phase of an Experimental Model of Epilepsy Induced by Pilocarpine
Marina Rascio Henriques Dutra, Regiane dos Santos Feliciano, Kalil Ribeiro Jacinto, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 29
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Ferenc Zádor, Gábor Nagy-Grócz, Gabriella Kékesi, et al.
Molecules (2019) Vol. 24, Iss. 20, pp. 3709-3709
Open Access | Times Cited: 26
Individualized Immunological Data for Precise Classification of OCD Patients
Hugues Lamothe, Jean–Marc Baleyte, Pauline Smith, et al.
Brain Sciences (2018) Vol. 8, Iss. 8, pp. 149-149
Open Access | Times Cited: 24
Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Yifei Lü, Mingmei Shao, Tao Wu
Food Science & Nutrition (2020) Vol. 8, Iss. 2, pp. 711-719
Open Access | Times Cited: 21
Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia
Maju Mathew Koola, Samir Kumar Praharaj, Anilkumar Pillai
Current Behavioral Neuroscience Reports (2019) Vol. 6, Iss. 2, pp. 37-50
Open Access | Times Cited: 22
Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis
Stephanie Fryar-Williams, Jörg Strobel, Peter R. Clements
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15296-15296
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top